Achieve Life Sciences, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ACHV Nasdaq 2836 www.achievelifesciences.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Achieve Life Sciences, Inc.

Achieve Life Sciences Presents 52-Week Cytisinicline Results for Smoking and Vaping Cessation at CHEST 2026 - Oct 21st, 2026 6:30 am
Lisata adds biopharma finance veteran Jeffrey Farrow to board - Oct 15th, 2026 6:41 am
Lisata Therapeutics Appoints Jeff Farrow to Board of Directors - Oct 14th, 2026 2:05 pm
Achieve Life Sciences Appoints Kaitlyn Tuson as Senior Vice President, Marketing and Communications - Oct 7th, 2026 6:30 am
Achieve Life Sciences Announces Granting of New Hire Inducement Awards - Oct 6th, 2026 2:02 pm
Achieve Life Sciences Appoints Benjamin Halladay as Chief Financial Officer - Oct 1st, 2026 6:30 am
Achieve Life Sciences to Present 52-Week Cytisinicline Efficacy Data for Smoking and E-Cigarette Cessation at CHEST 2026 - Sep 28th, 2026 6:30 am
ACHV: Looking Ahead to Resubmission - Aug 18th, 2026 4:21 am
Achieve Life Sciences Stock Has Nearly Tripled in the Last Year. Now It Just Needs to Turn a Profit. - Aug 12th, 2026 11:10 am
Achieve Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Updates - Aug 11th, 2026 6:30 am
Achieve Life Sciences Appoints Ronald Dadino and Gloria Cosgrove to Lead CMC, Supply Chain, and Quality - Aug 3rd, 2026 6:30 am
Achieve Life Sciences Announced Granting of New Hire Inducement Awards - Jul 31st, 2026 6:30 am
Achieve Life Sciences Stockholders Weigh Board Slate, Share Increase at Annual Meeting - Jul 9th, 2026 6:01 pm
Achieve Life Sciences Joins Russell 2000® Index - Jun 29th, 2026 6:30 am
Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA - Jun 22nd, 2026 6:30 am
Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors - Jun 2nd, 2026 6:30 am
Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment - May 19th, 2026 12:15 pm